Evidence map›Paper›PMID 31139082›Full record

ArticleFrontiers in pharmacology2019

Pterostilbene Activates the Nrf2-Dependent Antioxidant Response to Ameliorate Arsenic-Induced Intracellular Damage and Apoptosis in Human Keratinocytes.

Junfeng Zhou, Xinxin Ci, Xiaoyuan Ma, Qinlei Yu, Yan Cui, Yu Zhen, Shanshan Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Review
  11. The Beneficial Effects of Pterostilbene on Post-Thawed Bovine Spermatozoa.Animals : an open access journal from MDPI · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Junfeng ZhouDepartment of Dermatology and Venereology, The First Hospital of Jilin University, Changchun, China.
Xinxin CiInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun, China.
Xiaoyuan MaGeneral Situation of Jilin Provincial Center for Animal Disease Control and Prevention, Jilin University, Changchun, China.
Qinlei YuGeneral Situation of Jilin Provincial Center for Animal Disease Control and Prevention, Jilin University, Changchun, China.
Yan CuiDepartment of Dermatology and Venereology, The First Hospital of Jilin University, Changchun, China.
Yu ZhenDepartment of Dermatology and Venereology, The First Hospital of Jilin University, Changchun, China.
Shanshan LiDepartment of Dermatology and Venereology, The First Hospital of Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The NF-E2 p45-related factor 2 (Nrf2), a transcription factor that regulates the cellular adaptive response to oxidative stress, is a target for limiting tissue damage from exposure to environmental toxins, including arsenic. In the current study, we determine whether Pterostilbene (Pts), as a potent activator of Nrf2, has a protective effect on arsenic-induced cytotoxicity and apoptosis in human keratinocytes. Human keratinocytes (HaCaT) or mouse epidermal cells (JB6) were pretreated with Pts for 24 h prior to arsenic treatment. Harvested cells were analyzed by MTT, DCFH-DA, commercial kits, Flow cytometry assay and western blot analysis. Our results demonstrated that Pts effectively regulated the viability in HaCaT and JB6 cells, decreased the reactive oxygen species (ROS) generation and lipid peroxidation (MDA), and improved the NaAsO

Indexed as

apoptosisarsenickeratinocytesNrf2pterostilbene

Identifiers

PMID31139082
PMCPMC6519314
OpenAlexW2944541633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.